The story of Viagra and its originator, copyright, presents a complex picture for cautious investors. While the revolutionary drug initially produced enormous profits , its patent has expired , leading to rival alternatives flooding the arena. This erosion in cost presents a significant obstacle for copyright and any fund considering a significa… Read More